Company Name: Transcell Biologics
Funding Amount : Undisclosed
Investor(s) Indian Angel Network
Funding Round: Angel round
Hyderabad-based biotech startup, Transcell Biologics has raised an undisclosed amount of investment from Indian Angel Network (IAN), the company announced today.
Sanjay Jesrani, who has led this round of investment will be joining the board of Transcell on behalf of IAN.
Transcell Biologics is a biotech enterprise with a focus on developing stem cell based products portfolio. It was started in 2009 by Dr. Subhadra Dravida who has 16 years of experience in Stem cell research and commercialization.
The company plans to utilize the investment raised for productization of the stem cell based platforms in both the therapeutic and non-therapeutic areas.
Transcell’s most successful innovation has been the development of a novel proprietary process for maximizing the stem cell therapeutic yield that also maintains the native pluripotent properties and inherent functionality; and a proprietary cell-based product to treat ovarian cancers prototype.
In 2011, Transcell had set up a stem cell bank and a research centre in Hyderabad at an investment of around Rs 20 crore.
Commenting on the investment, Sanjay Jesrani said, “Last few years we have seen Stem cell banks becoming quite popular in India. With the advancement in technology, newer players are entering the market with an aim to preserve precious lives of the coming generation. Transcell Biologics is one such company who wants to help the needy with the support of their homegrown technologies.”
“We are thankful to IAN for believing in our passion, capabilities in making a positive impact on the end users, of the discoveries in modern medicine. We value the support and guidance from them, positioning ourselves and continue to strive to give back to the communities by translating advanced scientific technologies reaching clinics,” said Dr. Subhadra Dravida.
